These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2890673)

  • 1. Treatment of negative symptoms in schizophrenia with zotepine.
    Barnas C; Stuppaeck C; Unterweger B; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1987 Oct; 7(5):370-1. PubMed ID: 2890673
    [No Abstract]   [Full Text] [Related]  

  • 2. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
    Fleischhacker WW; Barnas C; Stuppäck C; Unterweger B; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Int Clin Psychopharmacol; 1992; 7(1):23-7. PubMed ID: 1352521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 6. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zotepine for schizophrenia.
    Fenton M; Morris S; De-Silva P; Bagnall A; Cooper SJ; Gammelin G; Leitner M
    Cochrane Database Syst Rev; 2000; (2):CD001948. PubMed ID: 10796671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectivity of zotepine in refractory psychoses: possible relationship between zotepine and non-dopamine psychosis.
    Harada T; Otsuki S; Sato M; Wake A; Fujiwara Y; Kashihara K; Fukuda K
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):47-51. PubMed ID: 2883682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.
    Cooper SJ; Butler A; Tweed J; Welch C; Raniwalla J
    Psychopharmacology (Berl); 2000 Jun; 150(3):237-43. PubMed ID: 10923750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zotepine in the treatment of acute hospitalized schizophrenic episodes.
    Kasper S; Quiner S; Barnas C; Fabisch H; Haushofer M; Sackel C; König P; Lingg A; Platz T; Rittmannsberger H; Stuppäck C; Willeit M; Zapotoczky HG
    Int Clin Psychopharmacol; 2001 May; 16(3):163-8. PubMed ID: 11354238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW; Stuppäck C; Barnas C; Unterweger B; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zotepine-induced spontaneous ejaculation.
    Wang PW; Wang SY; Huang CJ
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):571-3. PubMed ID: 19000555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
    Pai MS; Yang SN; Shiah IS
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):538. PubMed ID: 23066778
    [No Abstract]   [Full Text] [Related]  

  • 19. Zotepine: a clinical review.
    Green B
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):181-6. PubMed ID: 19199377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.